Furthermore, AITL patients with the high expression of both TLR9 and PD-L1 had the worst overall survival rate than patients with the single-high and double low expression (15 vs. 45 months; Log-rank P=0.007; Fig. 4F). The gene discussed is TLR9; the disease is angioimmunoblastic T-cell lymphoma.